138 related articles for article (PubMed ID: 25287167)
1. A polymorphism in the microsomal triglyceride transfer protein can predict the response to antiviral therapy in Egyptian patients with chronic hepatitis C virus genotype 4 infection.
Saad Y; Shaker O; Nassar Y; Ahmad L; Said M; Esmat G
Gut Liver; 2014 Nov; 8(6):655-61. PubMed ID: 25287167
[TBL] [Abstract][Full Text] [Related]
2. IL28B polymorphism and cytomegalovirus predict response to treatment in Egyptian HCV type 4 patients.
El Awady MK; Bader El Din NG; Tabll A; El Hosary Y; Abdel Aziz AO; El Khayat H; Salama M; Abdelhafez TH
World J Gastroenterol; 2013 Jan; 19(2):290-8. PubMed ID: 23345953
[TBL] [Abstract][Full Text] [Related]
3. Association between hepatic steatosis and MTP gene -493G/T polymorphism in the patients with HCV genotype 1 infection.
Akgöllü E; Akkız H
Infect Genet Evol; 2019 Jun; 70():101-106. PubMed ID: 30790698
[TBL] [Abstract][Full Text] [Related]
4. Association of interleukin-28B rs12979860 and rs8099917 polymorphisms with sustained viral response in hepatitis C virus genotype 1 and 3 infected patients from the Indian subcontinent.
Ranjan P; Fletcher GJ; Radhakrishnan M; Sivakumar J; Premkumar PS; Goel A; Zachariah UG; Abraham P
Indian J Med Microbiol; 2016; 34(3):335-41. PubMed ID: 27514956
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of
Świątek-Kościelna B; Kałużna E; Strauss E; Nowak J; Bereszyńska I; Gowin E; Wysocki J; Rembowska J; Barcińska D; Mozer-Lisewska I; Januszkiewicz-Lewandowska D
World J Gastroenterol; 2017 Jun; 23(21):3815-3824. PubMed ID: 28638221
[TBL] [Abstract][Full Text] [Related]
6. Genetic variation in the microsomal triglyceride transfer protein (-493G/T) is associated with hepatic steatosis in patients infected with hepatitis C virus.
Magri MC; Prata TV; Manchiero C; Dantas BP; Mazza CC; Tengan FM
BMC Infect Dis; 2017 Mar; 17(1):235. PubMed ID: 28356060
[TBL] [Abstract][Full Text] [Related]
7. Association of Myxovirus Resistance Gene Promoter Polymorphism with Response to Combined Interferon Treatment and Progression of Liver Disease in Chronic HCV Egyptian Patients.
Bader El Din NG; Salum GM; Anany MA; Ibrahim MK; Dawood RM; Zayed N; El Abd YS; El-Shenawy R; El Awady MK
J Interferon Cytokine Res; 2015 Aug; 35(8):641-8. PubMed ID: 25868067
[TBL] [Abstract][Full Text] [Related]
8. Polymorphism of the IL28B gene (rs8099917, rs12979860) and virological response of Pakistani hepatitis C virus genotype 3 patients to pegylated interferon therapy.
Aziz H; Raza A; Ali K; Khattak JZ; Irfan J; Gill ML
Int J Infect Dis; 2015 Jan; 30():91-7. PubMed ID: 25462177
[TBL] [Abstract][Full Text] [Related]
9. Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4.
Ragheb MM; Nemr NA; Kishk RM; Mandour MF; Abdou MM; Matsuura K; Watanabe T; Tanaka Y
Liver Int; 2014 Jul; 34(6):890-5. PubMed ID: 24102823
[TBL] [Abstract][Full Text] [Related]
10. Microsomal triglyceride transfer protein polymorphism (-493G/T) is associated with hepatic steatosis in patients with chronic hepatitis C.
Mirandola S; Osterreicher CH; Marcolongo M; Datz C; Aigner E; Schlabrakowski A; Realdon S; Gerotto M; Alberti A; Stickel F
Liver Int; 2009 Apr; 29(4):557-65. PubMed ID: 19018985
[TBL] [Abstract][Full Text] [Related]
11. Microsomal triglyceride transfer protein (MTP) -493G/T gene polymorphism contributes to fat liver accumulation in HCV genotype 3 infected patients.
Zampino R; Ingrosso D; Durante-Mangoni E; Capasso R; Tripodi MF; Restivo L; Zappia V; Ruggiero G; Adinolfi LE
J Viral Hepat; 2008 Oct; 15(10):740-6. PubMed ID: 18482281
[TBL] [Abstract][Full Text] [Related]
12. Using early viral kinetics to predict antiviral outcome in response-guided pegylated interferon plus ribavirin therapy among patients with hepatitis C virus genotype 1.
Oze T; Hiramatsu N; Yakushijin T; Miyazaki M; Iio S; Oshita M; Hagiwara H; Mita E; Inui Y; Hijioka T; Inada M; Tamura S; Yoshihara H; Inoue A; Imai Y; Miyagi T; Yoshida Y; Tatsumi T; Kanto T; Kasahara A; Hayashi N; Takehara T
J Gastroenterol; 2014 Apr; 49(4):737-47. PubMed ID: 23689988
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 28B-related polymorphisms: a pathway for understanding hepatitis C virus infection?
Garcia RF; Moreira S; de Araújo Ramos AL; Ferreira LE; de Mattos AA; Tovo CV; Nader LA; Ramos JA; Rondinelli E; de Jesus Dominici A; Garcia CE; de Souza Leite Pinho M; Brandão-Mello CE; Villela-Nogueira CA; de França PH
World J Gastroenterol; 2013 Nov; 19(42):7399-404. PubMed ID: 24259970
[TBL] [Abstract][Full Text] [Related]
14. Association between IFN-λ 3 Gene Polymorphisms and Outcome of Treatment with Direct Acting Antivirals in Chronic HCV-Infected Egyptian Patients.
El-Garawani I; Hassab El-Nabi S; Gadallah M; Abdelsameea E
Immunol Invest; 2021 Jan; 50(1):12-22. PubMed ID: 32024403
[No Abstract] [Full Text] [Related]
15. Low-density lipoprotein receptor genetic polymorphism in chronic hepatitis C virus Egyptian patients affects treatment response.
Naga M; Amin M; Algendy D; Elbadry A; Fawzi M; Foda A; Esmat S; Sabry D; Rashed L; Gabal S; Kamal M
World J Gastroenterol; 2015 Oct; 21(39):11141-51. PubMed ID: 26494968
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-28b CC genotype predicts early treatment response and CT/TT genotypes predicts non-response in patients infected with HCV genotype 3.
Gupta AC; Trehanpati N; Sukriti S; Hissar S; Midha V; Sood A; Sarin SK
J Med Virol; 2014 Apr; 86(4):707-12. PubMed ID: 24415442
[TBL] [Abstract][Full Text] [Related]
17. Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy.
El Awady MK; Anany MA; Esmat G; Zayed N; Tabll AA; Helmy A; El Zayady AR; Abdalla MS; Sharada HM; El Raziky M; El Akel W; Abdalla S; Bader El Din NG
J Gastroenterol Hepatol; 2011 May; 26(5):843-50. PubMed ID: 21182542
[TBL] [Abstract][Full Text] [Related]
18. IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C.
Fattovich G; Covolo L; Bibert S; Askarieh G; Lagging M; Clément S; Malerba G; Pasino M; Guido M; Puoti M; Gaeta GB; Santantonio T; Raimondo G; Bruno R; Bochud PY; Donato F; Negro F;
Aliment Pharmacol Ther; 2011 May; 33(10):1162-72. PubMed ID: 21443535
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D-related gene polymorphism predict treatment response to pegylated interferon-based therapy in Thai chronic hepatitis C patients.
Thanapirom K; Suksawatamnuay S; Sukeepaisarnjaroen W; Tangkijvanich P; Treeprasertsuk S; Thaimai P; Wasitthankasem R; Poovorawan Y; Komolmit P
BMC Gastroenterol; 2017 Apr; 17(1):54. PubMed ID: 28415985
[TBL] [Abstract][Full Text] [Related]
20. Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients.
Haj-Sheykholeslami A; Keshvari M; Sharafi H; Pouryasin A; Hemmati K; Mohammadzadehparjikolaei F
World J Gastroenterol; 2015 Aug; 21(29):8935-42. PubMed ID: 26269684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
